John P. Hamill
SrVP/CFO/Prin Fin & Acct Ofcr · Aprea Therapeutics, Inc.
- 2024
- Apr 1, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John P. Hamill files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Richard Peters - $100K in APRE purchases and sales in the last 12 months
- Oren Gilad - $25K in APRE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John P. Hamill?
John P. Hamill is a corporate insider, tracked as SrVP/CFO/Prin Fin & Acct Ofcr of Aprea Therapeutics, Inc. (APRE). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did John P. Hamill last file a Form 4?
The most recent primary Form 4 on record is dated 1 April 2026, one of 5 filings going back to 2024.
Has John P. Hamill been buying or selling stock?
Recorded transactions: 6 open-market purchases ($31K) and 0 open-market sales across all tracked filings.
